These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats. Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808 [TBL] [Abstract][Full Text] [Related]
5. Role of spinal cholecystokinin in neuropathic pain after spinal cord hemisection in rats. Kim J; Kim JH; Kim Y; Cho HY; Hong SK; Yoon YW Neurosci Lett; 2009 Oct; 462(3):303-7. PubMed ID: 19619609 [TBL] [Abstract][Full Text] [Related]
6. Peripheral axotomy influences the in vivo release of cholecystokinin in the spinal cord dorsal horn-possible involvement of cholecystokinin-B receptors. Gustafsson H; de Araújo Lucas G; Schött E; Stiller CO; Alster P; Wiesenfeld-Hallin Z; Brodin E Brain Res; 1998 Apr; 790(1-2):141-50. PubMed ID: 9593865 [TBL] [Abstract][Full Text] [Related]
7. Increased level of cholecystokinin in cerebrospinal fluid is associated with chronic pain-like behavior in spinally injured rats. Xu XJ; Alster P; Wu WP; Hao JX; Wiesenfeld-Hallin Z Peptides; 2001 Aug; 22(8):1305-8. PubMed ID: 11457525 [TBL] [Abstract][Full Text] [Related]
8. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Xu XJ; Hao JX; Aldskogius H; Seiger Å; Wiesenfeld-Hallin Z Pain; 1992 Feb; 48(2):279-290. PubMed ID: 1589248 [TBL] [Abstract][Full Text] [Related]
9. Long-term alleviation of allodynia-like behaviors by intrathecal implantation of bovine chromaffin cells in rats with spinal cord injury. Yu W; Hao JX; Xu XJ; Saydoff J; Haegerstrand A; Hökfelt T; Wiesenfeld-Hallin Z Pain; 1998 Feb; 74(2-3):115-22. PubMed ID: 9520225 [TBL] [Abstract][Full Text] [Related]
10. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats. Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095 [TBL] [Abstract][Full Text] [Related]
11. The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury. Wu WP; Hao JX; Xu XJ; Wiesenfeld-Hallin Z; Koek W; Colpaert FC Eur J Pharmacol; 2003 Oct; 478(2-3):131-7. PubMed ID: 14575797 [TBL] [Abstract][Full Text] [Related]
12. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats. Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats. Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147 [TBL] [Abstract][Full Text] [Related]
14. Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Kovelowski CJ; Ossipov MH; Sun H; Lai J; Malan TP; Porreca F Pain; 2000 Sep; 87(3):265-273. PubMed ID: 10963906 [TBL] [Abstract][Full Text] [Related]
15. Allodynia-like effects in rat after ischaemic spinal cord injury photochemically induced by laser irradiation. Hao XJ; Xu JX; Aldskogius H; Seiger Å; Wiesenfeld-Hallin Z Pain; 1991 May; 45(2):175-185. PubMed ID: 1652116 [TBL] [Abstract][Full Text] [Related]
16. Lacosamide, a new anti-epileptic, alleviates neuropathic pain-like behaviors in rat models of spinal cord or trigeminal nerve injury. Hao JX; Stöhr T; Selve N; Wiesenfeld-Hallin Z; Xu XJ Eur J Pharmacol; 2006 Dec; 553(1-3):135-40. PubMed ID: 17092498 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study. Sullivan AF; Hewett K; Dickenson AH Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat. Yamamoto T; Sakashita Y Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787 [TBL] [Abstract][Full Text] [Related]
20. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7105-9. PubMed ID: 1698290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]